Effects on gamma-aminobutyric acid (GABA)(A) receptors of a neuroactive steroid that negatively modulates glutamate neurotransmission and augments GABA neurotransmission
S. Mennerick et al., Effects on gamma-aminobutyric acid (GABA)(A) receptors of a neuroactive steroid that negatively modulates glutamate neurotransmission and augments GABA neurotransmission, MOLEC PHARM, 60(4), 2001, pp. 732-741
Neurosteroids positively and negatively modulate gamma -aminobutyric acid (
GABA)(A) receptors and glutamate receptors, which underlie most fast inhibi
tion and excitation in the central nervous system. We report the identifica
tion of a neuroactive steroid, (3 alpha ,5 beta)-20-oxo-pregnane-3-carboxyl
ic acid (3 alpha5 beta PC), with unique cellular actions. 3 alpha5 beta PC
positively modulates GABAA receptor function and negatively modulates N-met
hyl-D-aspartate (NMDA) receptor function, a combination that may be of part
icular clinical benefit. 3 alpha5 beta PC promotes net GABA(A) potentiation
at low steroid concentrations (<10 <mu>M) and at negative membrane potenti
als. At higher concentrations, the steroid also blocks GABA receptors. Beca
use this block would presumably counteract the NMDA receptor blocking actio
ns of 3 alpha5 beta PC, we characterize the GABA receptor block in some det
ail. Agonist concentration, depolarization, and high extracellular pH incre
ase the block. The apparent pK for both potentiation and block was 6.4 to 6
.9, substantially higher than expected from carboxylated steroid in an aque
ous environment. Block is not dependent on the stereochemistry of the carbo
xylic acid at carbon 3 and is relatively insensitive to placement of the ca
rboxylic acid at the opposite end of the steroid (carbon 24). Potentiation
is critically dependent on the stereochemistry of the carboxylic acid group
at carbon 3. Consistent with the pH dependence of potentiation, effects of
the amide derivative (3 alpha ,5 beta)-20-oxo-pregnane-3-carboxamide, sugg
est that the unionized form of 3 alpha5 beta PC is important for potentiati
on, whereas the ionized form is probably responsible for block. Further ref
inement of the neuroactive steroid to promote GABA potentiation and NMDA re
ceptor block and diminish GABA receptor block may lead to a clinically usef
ul neuroactive steroid.